Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 10, 1995, Pages 2966-2973

  Apter, D ^a,b   Butzow T ^a   Laughlin, G A ^a   Yen, S S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ylioppilaiden Teru Hoitosäätio ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BINDING PROTEIN; ESTRONE; HYDROXYPROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN RESPONSE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCHOOL CHILD;

17-HYDROXYPROGESTERONE; ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; BLOOD GLUCOSE; CHILD; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HIRSUTISM; HUMAN; HYDROXYPROGESTERONES; INSULIN; INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN 1; LUTEINIZING HORMONE; MENARCHE; MENSTRUATION; OLIGOMENORRHEA; OVARY; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TESTOSTERONE;

EID: 0028889654     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.10.7559882     Document Type: Article

References (44)

1. Bloch CA, Clemons P, Sperling MA. 1987 Puberty decreases insulin sensitivity. J Pediatr. 110:481-487.
2. Smith CP, Dünger DB, Williams AJK, et al. 1989 Relationship between insulin, insulin-like growth factor I, and dehydroepiandro-sterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab. 68:932-937.
3. Lindgren F, Dahlquist G, Efendic S, Persson B, Skottner A. 1990 Insulin sensitivity and glucose-induced insulin response changes during adolescence. Acta Paediatr Scand. 79:431-436.
4. Hindmarsh P, Di SL, Pringle PJ, Kurtz AB, Brook CG. 1988 Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clin Endocrinol (Oxf). 28:381-388.
5. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. 1994 Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab. 78:1195-1201.
6. Savage MO, Smith CP, Dünger DB, Gale EA, Holly JM, Preece MA. 1992 Insulin and growth factors adaptation to normal puberty. Horm Res. 3:70-73
7. Argente J, Barrios V, Pozo J, et al. 1993 Normative data for insulinlike growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab. 77:1522-1528.
8. Cook JS, Hoffman RP, Stene MA, Hansen JR. 1993 Effects of mat-urational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab. 77:725-730.
9. Holly JMP, Smith CP, Dunger DB, et al. 1989 Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I: a synchronized approach to pubertal development? Clin Endocrinol (Oxf). 31:277-284.
10. Apter D, Bolton NJ, Hammond GL, Vihko R. 1984 Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinol (Copenh). 107:413-419.
11. Apter D. 1980 Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol (Oxf). 12:107-120.
12. Apter D, Biitzow TL, Laughlin GA, Yen SSC. 1994 Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab. 79:119-125.
13. Yen SSC. 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177-207.
14. Barnes RB, Rosenfield RL, Burstein S, Erhmann DA. 1989 Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 320:559-565.
15. Ferriman D, Gallwey JD. 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1440-1447.
16. Holden JP, Biitzow TL, Laughlin GA, Ho M, Morales AJ, Yen SSC. 1995 Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) during the 24h metabolic clock and in response to hy-poinsulinemia induced by fasting and Sandostatin in normal women. J Soc Gyn Invest. 2:38-44.
17. Yen S, Samaan N, Pearson O. 1967 Growth hormone levels in pregnancy. Clin Endocrinol Metab. 27:1341-1347.
18. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-490.
19. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
20. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. Clin Endocrinol Metab. 75:577-583.
21. Rosenbaum D, Haber RS, Dunaif A. 1993 Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am Physiol. 264:E197-202.
22. Nestler JE, Powers LP, Matt DW, et al. 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 72:83-89.
23. Holte J, Bergh T, Berne C, Berglund L, Lithell H. 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78:1052-1058.
24. Laughlin GA, Morales AJ, Apter D. Effects of age and adiposity on pulsatile secretion of growth hormone (GH) in women. 75th Annual Meeting of The Endocrine Society, Las Vegas, NV, 1993. (Abstract 685)
25. Iranmanesh A, Lizzarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73: 1081-1088.
26. Holly JMP. 1991 The physiological role of IGFBP-1. Acta Endocrinol (Copenh). 124:55-62.
27. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989 Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab. 68:135-140.
28. Kazer R, Unterman TG, Glick RP. 1990 An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 71:958-962.
29. Prevelic GM, Wurzburger MI, Balint-Peric I, Ginsburg J. 1992 Twenty-four hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-1 concentrations in women with polycystic ovaries. Horm Res. 37:125-131.
30. Insler V, Barash A, Shoham Z, et al. 1993 Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanisms based on new interpretation of facts and findings. Hum Re-prod. 8:379-384.
31. Slowinska-Srzednicka J, Zgliczynski W, Makowska A, et al. 1992 An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab. 74:1432-1435.
32. Pache TD, de Jong FH, Hop WC, Fauser BC. 1993 Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril. 59:544-549.
33. Filicori M, Flamigni C, Cognigni G, Dellai P, Michelacci L, Arnone R. 1994 Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Fertil Steril. 62:279-285.
34. DeClue TJ, Shah SC, Marchese M, Malone JI. 1991 Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab. 72:1308-1311.
35. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
36. Barbieri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 50: 197-203.
37. El-Roeiy A, Chen X, Roberts V, et al. 1994 Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab. 78:1488-1496.
38. Conway GS, Jacobs HS, Holly JMP, Wass JAH. 1990 Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein-1 in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 33:593-603.
39. Stuart CA, Prince MJ, Peters EJ, et al. 1987 Hyperinsulinemia and hyperandrogenism: in vivo androgen response to insulin infusion. Obstet Gynecol. 69:921-925.
40. Antilla L, Koskinen P, Jaatinen T-A, Erkkola R, Irjala K, Ruutiainen K. 1993 Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum Reprod. 8:1179-1183.
41. Dunaif A, Graf M. 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome. J Clin Invest. 83:23-29.
42. Poretsky L. 1994 Insulin resistance and hyperandrogenism: update 1994. Endocr Rev. 2:125-129.
43. Nestler JE, Clore JN, Blackard WG. 1989 The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol. 161:1095-1097.
44. Pasquali R, Casimirri F. 1993 The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf). 39:1-16.